BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 26914553)

  • 1. Bilateral Renal Involvement in Mantle Cell Lymphoma on FDG PET/CT.
    Mukherjee A; Agarwal KK; Gogia A; Bal C; Kumar R
    Clin Nucl Med; 2016 Apr; 41(4):e206-7. PubMed ID: 26914553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluorodeoxyglucose-positron-emission tomography findings in mantle cell lymphoma.
    Alavi A; Shrikanthan S; Aydin A; Talanow R; Schuster S
    Clin Lymphoma Myeloma Leuk; 2011 Jun; 11(3):261-6. PubMed ID: 21658653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ¹⁸F-FDG PET/CT imaging for a gastrointestinal mantle cell lymphoma with multiple lymphomatous polyposis.
    Saito M; Miyazaki M; Tanino M; Tanaka S; Miyashita K; Izumiyama K; Mori A; Irie T; Tanaka M; Morioka M; Tsukamoto E
    World J Gastroenterol; 2014 May; 20(17):5141-6. PubMed ID: 24803832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis of mantle-cell lymphoma relapse by 18F-FDG PET/CT after water gastric distention.
    Banzo I; Martínez-Rodríguez I; Quirce R; Jiménez-Bonilla J; Carril JM
    Clin Nucl Med; 2014 Oct; 39(10):931-3. PubMed ID: 24999694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spontaneous regression of follicular, mantle cell, and diffuse large B-cell non-Hodgkin's lymphomas detected by FDG-PET imaging.
    Kumar R; Bhargava P; Zhuang H; Yu JQ; Schuster SJ; Alavi A
    Clin Nucl Med; 2004 Nov; 29(11):685-8. PubMed ID: 15483478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Positron emission tomography in mantle cell lymphoma.
    Brepoels L; Stroobants S; De Wever W; Dierickx D; Vandenberghe P; Thomas J; Mortelmans L; Verhoef G; De Wolf-Peeters C
    Leuk Lymphoma; 2008 Sep; 49(9):1693-701. PubMed ID: 18798104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Positron Emission Tomography-based Analysis Can Accurately Predict Bone Marrow Involvement With Mantle Cell Lymphoma.
    Morgan R; Perry M; Kwak J; Jensen A; Kamdar M
    Clin Lymphoma Myeloma Leuk; 2018 Nov; 18(11):731-736. PubMed ID: 30075973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Giant Cell Tumor of the Tendon Sheath With Discordant Metabolism as a False Positive on Staging of Mantle Cell Lymphoma.
    Rezaee A; Chen W; Dilsizian V; Chen Q; Kimball AS
    Clin Nucl Med; 2015 Oct; 40(10):814-5. PubMed ID: 26053722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 18F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance in Lymphoma: Comparison With 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography and With the Addition of Magnetic Resonance Diffusion-Weighted Imaging.
    Giraudo C; Raderer M; Karanikas G; Weber M; Kiesewetter B; Dolak W; Simonitsch-Klupp I; Mayerhoefer ME
    Invest Radiol; 2016 Mar; 51(3):163-9. PubMed ID: 26784400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perirenal Involvement of Mantle Cell Lymphoma: Imaging Features.
    Ufuk F; Karaman E; Karabulut N
    Urology; 2016 Nov; 97():e1-e3. PubMed ID: 27233934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. "Hood Sign" in Nuclear Medicine: An Unusual Presentation of Mantle Cell Lymphoma as Detected on FDG PET/CT.
    Prakash A; Purandare N; Shah S; Agrawal A; Puranik A; Rangarajan V
    Clin Nucl Med; 2022 Dec; 47(12):e731-e732. PubMed ID: 35961639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 18F-FDG PET/CT in a case of bilateral lacrimal gland infiltration by mantle cell lymphoma.
    Martínez-Esteve A; García-Gómez FJ; Borrero-Martin JJ; Fajardo-Pico E; Borrego-Dorado I
    Rev Esp Med Nucl Imagen Mol; 2015; 34(6):396-7. PubMed ID: 25956958
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparison between whole-body MRI with diffusion-weighted imaging and PET/CT in staging newly diagnosed FDG-avid lymphomas.
    Albano D; Patti C; La Grutta L; Agnello F; Grassedonio E; Mulè A; Cannizzaro G; Ficola U; Lagalla R; Midiri M; Galia M
    Eur J Radiol; 2016 Feb; 85(2):313-8. PubMed ID: 26781135
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Albano D; Treglia G; Gazzilli M; Cerudelli E; Giubbini R; Bertagna F
    Clin Lymphoma Myeloma Leuk; 2020 Jul; 20(7):422-430. PubMed ID: 32169480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 18F-FDG PET/CT in Intramuscular Mantle Cell Lymphoma With Elongated Lymphomatous Neurovascular Extension.
    Hod N; Levin D; Anconina R; Ezroh Kazap D; Lantsberg S
    Clin Nucl Med; 2019 Apr; 44(4):e298-e300. PubMed ID: 30688737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 18F-FDG PET for Measurement of Response and Prediction of Outcome to Relapsed or Refractory Mantle Cell Lymphoma Therapy with Bendamustine-Rituximab.
    Lamonica D; Graf DA; Munteanu MC; Czuczman MS
    J Nucl Med; 2017 Jan; 58(1):62-68. PubMed ID: 27469362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of small bowel involvement by mantle cell lymphoma on F-18 FDG positron emission tomography.
    Sam JW; Levine MS; Farner MC; Schuster SJ; Alavi A
    Clin Nucl Med; 2002 May; 27(5):330-3. PubMed ID: 11953565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 18F-FDG PET/CT finding of bilateral primary breast mucosa-associated lymphoid tissue lymphoma.
    Kim DH; Jeong JY; Lee SW; Lee J; Ahn BC
    Clin Nucl Med; 2015 Feb; 40(2):e148-9. PubMed ID: 25140550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [18F]fluorodeoxyglucose positron emission tomography scanning for staging, response assessment, and disease surveillance in patients with mantle cell lymphoma.
    Gill S; Wolf M; Prince HM; Januszewicz H; Ritchie D; Hicks RJ; Seymour JF
    Clin Lymphoma Myeloma; 2008 Jun; 8(3):159-65. PubMed ID: 18650179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of Leptomeningeal Involvement by 18F-FDG-PET/CT in a Patient With Non-Hodgkin Lymphoma.
    Fonti R; Salvatore B; De Renzo A; Nicolai E; Del Vecchio S
    Clin Nucl Med; 2016 Feb; 41(2):169-72. PubMed ID: 26545028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.